Sarah Rapisardo
Clinical Molecular Genetics Durham, NC Medical Doctor
NPI 1528657848 CMS profile 9246584
4134 S Alston Ave Ste 104, Durham, NC 27713
General payments
$105
Research payments
$0
Ownership & investment interest
$0
Through program year 2023, Sarah Rapisardo of Durham, NC is reported in the CMS Open Payments database as having received $105 across 1 general payment and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $105 | 1 |
Beside peers
- Sarah Rapisardo
- North Carolina median
- Middle half of North Carolina
- National median
In program year 2025, general payments to Sarah Rapisardo were reported at $0. Among 34,409 North Carolina profiles paid that year, the median was $159 and the middle half received between $47 and $573.
Show as a table
| Year | Sarah Rapisardo | North Carolina median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $167 | $52–$671 | $163 |
| 2020 | $0 | $110 | $33–$382 | $114 |
| 2021 | $0 | $125 | $36–$459 | $132 |
| 2022 | $0 | $145 | $42–$538 | $149 |
| 2023 | $105 | $153 | $45–$549 | $160 |
| 2024 | $0 | $156 | $45–$572 | $164 |
| 2025 | $0 | $159 | $47–$573 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Related records
Clinical Molecular Genetics in North Carolina
Practitioners in the same specialty and state, ranked by reported value.
All Clinical Molecular Genetics
Everyone recorded under this specialty, nationwide.
Doctors in North Carolina
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.